Modified UCN2 peptide treatment improves skeletal muscle mass and function in mouse models of obesity-induced insulin resistance.
Borg ML, Massart J, De Castro Barbosa T, Archilla-Ortega A, Smith JAB, Lanner JT, Alsina-Fernandez J, Yaden B, Culver AE, Karlsson HKR, Brozinick JT, Zierath JR.
Borg ML, et al. Among authors: culver ae.
J Cachexia Sarcopenia Muscle. 2021 Oct;12(5):1232-1248. doi: 10.1002/jcsm.12746. Epub 2021 Aug 2.
J Cachexia Sarcopenia Muscle. 2021.
PMID: 34342159
Free PMC article.